- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00929656
Combined Neural and Behavioral Therapies to Enhance Stroke Recovery
Combining Neural and Behavioral Therapies to Enhance Stroke Recovery
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Limited recovery of upper extremity (UE) function post-stroke continues to be one of the greatest challenges faced in neurorehabilitation. There is an urgent unmet need to identify effective approaches to drive UE recovery in this population. In response to this challenge, the overall purpose of this proposed research plan is to develop rehabilitation interventions that restore UE motor recovery. Contemporary approaches to motor rehabilitation are based on evidence that behavioral experience drives cortical reorganization following neural injury. Although the rationale of driving the damaged motor cortex by focused training of the paretic UE appears straightforward, and has historically been the focus of rehabilitation, functional recovery remains limited. There remains a gap between this central neurobiological change and a meaningful behavioral change. There is a need, therefore, to augment or potentiate behavioral experience. This proposal will address this gap by examining two potential drivers of the lesioned hemisphere: 1) the non-lesioned hemisphere via engagement of the unaffected UE in behavioral training and 2) stimulation of the lesioned hemisphere via repetitive Transcranial Magnetic Stimulation (rTMS). This proposal builds on the foundation of the applicant's previous work which suggested that the contralesional, intact, hemisphere could be used to drive the lesioned hemisphere through bimanual movement. Additionally, it is possible to drive the lesioned hemisphere externally using rTMS to enhance cortical stimulation. Thus, pairing externally-driven enhancement of cortical excitability with internally-driven activation of the intact hemisphere during bilateral movements could combine to further increase excitability in the lesioned hemisphere and manifest improved movement capability of the paretic UE. The fundamental hypothesis guiding this proposal is that increased excitability of the lesioned cortex will improve behavioral function of the paretic UE post-stroke. To investigate the overall hypothesis the investigators will examine these drivers of cortical excitability and their role in UE recovery by addressing the following aims:
Specific Aim 1. Determine the magnitude of difference in central and behavioral changes in individuals with post-stroke hemiparesis randomized to a bilateral versus unilateral UE motor training program.
Specific Aim 2a. Determine the magnitude of difference in central and behavioral changes in individuals with post-stroke hemiparesis randomized to behavioral UE training compared to behavioral UE training + rTMS.
Specific Aim 2b. Determine the differential effects of rTMS on bilateral behavioral training compared to unilateral behavioral training as measured both centrally and behaviorally in individuals with post-stroke hemiparesis Post-stroke upper limb paresis and resultant loss of functional ability continues to present a barrier to those post-stroke in returning to full societal participation. Interventions that directly target the mechanism of hemiparesis, including decreased excitability of the lesioned hemisphere, are most likely to promote true recovery as opposed to the oft observed functional compensation in these individuals.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Florida
-
Gainesville, Florida, United States, 32608
- North Florida/South Georgia Veterans Health System, Gainesville, FL
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosis of 1st stroke > 6 months
- Sub-cortical stroke confirmed with CT or MRI
- Passive range of motion in bilateral shoulder and elbow within functional limits
- UE Fugl-Meyer shoulder/elbow subcomponent score between 15 - 25
- 18-80 years of age
Exclusion Criteria:
- Use of medications that may lower seizure threshold
- History of epilepsy, brain tumor, learning disorder, mental retardation, drug or alcohol abuse, dementia, major head trauma, or major psychiatric illness
- evidence of epileptiform activity on EEG obtained before beginning treatment
- history or radiographic evidence of arteriovenous malformation, intracortical hemorrhage, subarachnoid hemorrhage, or bilateral cerebrovascular disease,
- history of cortical stroke
- history of implanted pacemaker or medication pump, metal plate in skull, or metal objects in the eye or skull
- pregnancy
- pain in either upper extremity that would interfere with movement
- unable to understand 3-step directions
- orthopedic condition in back or UE or impaired corrected vision that would alter kinematics of reaching
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Real rTMS
Real rTMS + unimanual paretic UE training
|
rTMS application to lesioned hemisphere; 10 Hz, 1000 pulses
UE exercise for 4 hours (two hours 1:1 with therapist and two hours independent at home) for 16 sessions (4 sessions/week for 4 weeks)
|
|
Active Comparator: Sham rTMS
Sham rTMS + unimanual paretic UE training
|
UE exercise for 4 hours (two hours 1:1 with therapist and two hours independent at home) for 16 sessions (4 sessions/week for 4 weeks)
sham rTMS application to lesioned hemisphere; 10 Hz, 1000 pulses
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Wolf Motor Function Test Change
Time Frame: Change between Pre-intervention (baseline) to Post-intervention (4 wks following pre-intervention)
|
Change, in seconds, between Pre-intervention and post-intervention (4 wks following pre-intervention).
The time to complete 15 separate upper extremity functional tasks are recorded.
These 15 separate timed events are averaged to provide one time, in seconds.
This is considered an Activity Measure on the WHO ICF model.
|
Change between Pre-intervention (baseline) to Post-intervention (4 wks following pre-intervention)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Upper Extremity Fugl-Meyer Motor Assessment Change
Time Frame: Change Between Pre-intervention (baseline) to Post-intervention (4 wks following pre-intervention)
|
Change in Score from Pre-intervention to Post-Intervention.
This outcome measures arm motor control; the ability to move outside of pathologic synergistic patterns.
It is a measure of impairment in Body Structure/Function.
Total score ranges from 0-66, with 0 indicative of no movement and 66 considered normal motor control.
|
Change Between Pre-intervention (baseline) to Post-intervention (4 wks following pre-intervention)
|
|
Grip Strength Change
Time Frame: Change between Pre-intervention (baseline) to Post-intervention (4 wks following pre-intervention)
|
Change in Paretic hand grip strength from pre- to post-intervention.
Grip strength measured by hand-held dynamometer.
An average of 3 5-second trials was used for analysis.
|
Change between Pre-intervention (baseline) to Post-intervention (4 wks following pre-intervention)
|
|
Motor Activity Log - Amount of Use Change
Time Frame: Change Between Pre-intervention (baseline) to Post-intervention (4 wks following pre-intervention)
|
Self-Report Amount of Use of Paretic UE to complete 30 functional tasks.
Each task is reported on a 0-5 scale with "0" representing "did not use my paretic hand at all for that task" and "5" representing "I used my paretic hand as much as before the stroke to complete that task."
A "5" on each task would be considered "normal."
|
Change Between Pre-intervention (baseline) to Post-intervention (4 wks following pre-intervention)
|
|
Motor Activity Log - How Well Change
Time Frame: Change between Pre-intervention (baseline) to Post-intervention (4 wks following pre-intervention)
|
Self-Report of How Well paretic UE performed completing 30 functional tasks.
Each task is reported on a 0-5 scale with "0" representing "Unable to use my paretic hand to perform that task" and "5" representing "My paretic hand performs that task as well as it did before the stroke."
A "5" on each task would be considered "normal."
|
Change between Pre-intervention (baseline) to Post-intervention (4 wks following pre-intervention)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Dorian Kay Rose, PhD MS BS, North Florida/South Georgia Veterans Health System, Gainesville, FL
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- B6862-W
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
Clinical Trials on Real rTMS
-
Dr. Zahra Kazem-MoussaviCompleted
-
Aalborg UniversityCompletedTranscranial Magnetic Stimulation | Electroencephalography | Repetitive Transcranial Magnetic Stimulation | Motor Cortex | Pain ThresholdsDenmark
-
IRCCS Centro San Giovanni di Dio FatebenefratelliCompleted
-
Assistance Publique - Hôpitaux de ParisCompletedCerebrovascular Disorders | Cerebral Stroke | VISIO-spatial Neglect | VISUO-spatial ExtinctionFrance
-
Shanghai General Hospital, Shanghai Jiao Tong University...Recruiting
-
Institut GuttmannUnknown
-
NYU Langone HealthCompletedParkinson DiseaseUnited States
-
Shenyang Medical CollegeNot yet recruitingRecurrent Pregnancy Loss | Overweight , Obesity | Heart-Brain CouplingChina